CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology.
|Headquarters||310 Goddard Ste 150|
IRVINE, CA, United States 92618-4617
|Chairman of the Board||Robert Jessup|
|President, Chief Executive Officer, Director||Mark McDonough|
|Chief Financial Officer, Treasurer, Secretary||Scott Burell|
|Independent Director||Scott Gottlieb|
|Independent Director||Robert Hoffman|
|Shares Out.||845.4K||Book Value||$9.65|
|Annual Dividend Rate||0.00 USD||Price/Sales (TTM)||0.5|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||-68.61%|
*GAAP = prior to non-GAAP analyst adjusted earnings.